Surgical resection for hepatocellular carcinoma

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2008, Pages

  Abrishami, Amir ^a   Nasseri Moghaddam, S ^b   Eghtesad, B ^b   Sherman, M ^b  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL; REVIEW; SURGICAL RISK; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW;

EID: 44949123627     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006935     Document Type: Review

References (68)

1. Adam 2003 Adam R, Azoulay D, Castaing D, Eshkenazy R, Pascal G, Hashizume K, et al.Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy. Annual of Surgery 2003;238(4):518-9.
2. Badvie 2000 Badvie S. Hepatocellular carcinoma. Postgraduate Medical Journal 2000;76:4-11.
3. Bain 1997 Bain I, McMaster P. Benign and malignant liver tumours. Surgery 1997;15:169-74.
4. Begg 1994 Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50(4): 1088-101.
5. Bhoori 2007 Bhoori S, Schiavo M, Russo A, Mazzaferro V. First-line treatment for hepatocellular carcinoma: resection or transplantation?. Transplantation Proceedings 2007;39(7):2271-3.
6. Blum 2005 Blum HE. Hepatocellular carcinoma: therapy and prevention. World Journal of Gastroenterology 2005;11(47):7391- 400.
7. Bosch 2004 Bosch FX. Primary liver cancer. Gastroenterology 2004;127:S5-S16.
8. Botha 2007 Botha JF, Grant WJ, Shaw BW. Surgical options for the treatment of hepatocellular carcinoma. In: SchiffER, SorrellMF, MaddreyWC editor(s). Schiff's Diseases of the Liver. 10th Edition. Vol. 2, Philadelphia: Lippincott Williams & Wilkins, 2007:1266-71.
9. Bruix 1996 Bruix J. Surgical resection of hepatocellular carcinoma in cirrhotic patients. Gastroenterology 1996;111:1018-22.
10. Bruix 2005 Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-35.
11. Bruix 2006 Bruix J, Hessheimer AJ. New aspects of diagnosis and therapy of hepatocellular carcinoma. Oncogene 2006;25:3848-56.
12. Buyse 1987 Buyse M, Ryan LM. Issues of efficiency in combining proportions of deaths from several clinical trials. Statistics in Medicine 1987;6:565-76.
13. Capussotti 2006 Capussotti L, Muratore A, Amisano M, Massucco P, Polastri R, Bouzari H. Liver resection for large-size hepatocellular carcinomas in 47 non-cirrhotic patients - no mortality and long-term survival. Hepato-Gastroenterology 2006;53(71):768-72.
14. Clark 2005 Clark HP. Staging and current treatment of hepatocellular carcinoma. Radiologic Graphics 2005;25:S3-S23.
15. Collier 1998 Collier J, Sherman M. Screening for hepatocellular carcinoma. Hepatology 1998;27:273-8.
16. DeMets 1987 DeMets DL. Methods for combining randomized clinical trials: strengths and limitations. Statistics in Medicine 1987;6(3):341-50.
17. DerSimonian 1986 DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177-88.
18. Deuffic 1998 Deuffic S. Trends in primary liver cancer. Lancet 1998;351:214-5.
19. Dienstag 2005 Dienstag JL, Isselbacher KJ. Tumors of the liver and biliary tract. Harrison's Principle of Internal Medicine (http://www.accessmedicine.com/content.aspx?aID=62758). McGrow-Hill's Access Medicine, (accessed 13 March 2007):Chapter 78.
20. Egger 1997 Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical Research Ed.) 1997;315(7109):629-34.
21. El-Serag 2007 El-Serag HB. Epidemiology of hepatocellular carcinoma in USA. Hepatology Research 2007;37(Suppl 2):S88-94.
22. Farmer 1994 Farmer DG, Rosove MH. Current treatment modalities for HCC. Annual of Surgery 1994;219:236-47.
23. Fong 1999 Fong Y, Sun RL, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Annals of Surgery 1999;229(6):799-800.
24. Galandi 2004 Galandi D, Antes G. Radiofrequency thermal ablation versus other interventions for hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2004, Issue 2. Art. No.: CD003046. DOI:10.1002/14651858. CD003046.pub2.Art. No.: CD003046. DOI:10.1002/14651858.CD003046.pub2.
25. Gluud 2001 Gluud C. Alcoholic hepatitis: no glucocorticosteroids?. In: LeuschnerU, JamesOFW, DancygierH editor(s). Steatohepatitis (NASH and ASH), Falk Symposium. Dordrecht: Kluwer Academic Publishers, 2001:322-42.
26. Gluud 2007 Gluud C, Nikolova D, Klingenberg SL, Als-Nielsen B, D'Amico G, Davidson B, et al.Cochrane Hepato-Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2007, Issue 2. Art. No.: LIVER.
27. Grazi 2001 Grazi GL, Ercoliani G. Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Annual of Surgery 2001;234(1):71-8.
28. Higgins 2006 Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]. www.cochrane.org/resources/handbook/hbook.htm. Chichester, UK: John Wiley & sons, Ltd, (accessed November 2007).
29. ICH-GCP 1996 Guideline for Good Clinical Practice. International Conference on Harmonisation of Technical Requiements for Registration of Pharmaceuticals for Human Use 1996; Vol. 1.
30. Kim 2006 Kim WR, Therneau TM, Benson JT. Deaths on the liver transplant waiting list: an analysis of competing risks. Hepatology 2006;43(2):345-51.
31. Kjaergard 2001 Kjaergard LL, Villumsen J, Gluud C. Reported methodological quality and discrepancies between large and small randomized trials in meta-analyses. Annals of Internal Medicine 2001;135(11): 982-9.
32. Lencioni 1997 Lencioni R, Pinto F, Bassi AM, Moretti M, Di Giulio M, Marchi S, et al.Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: an European experience. European Radiology 1997;7:514-9.
33. Lencioni 2003 Lencioni RA, Allgaier HP, Cioni D, Olschewski M, Deibert P, Crocetti L, et al.Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003;228(1):235-40.
34. Lencioni 2005 Lencioni R, Cioni D. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 2005;234(3):961-7.
35. Liu 2004 Liu JH, Chen PW. Surgery for hepatocellular carcinoma: does it improve survival?. Annals of Surgical Oncology 2004;11:298-303.
36. Livraghi 1995 Livraghi T, Giorgio A, Marin G, Salmi A, de Sio I, Bolodi L, et al.Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995;197(1):101-8.
37. Llovet 1999 Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999;30:1434-40.
38. Llovet 2003 Llovet JM. Hepatocellular carcinoma. Lancet 2003;362:1907-17.
39. Llovet 2005 Llovet JM. Updated treatment approach to hepatocellular carcinoma. Journal of Gastroenterology 2005;40:225-35.
40. Marin 2003 Marin-Hargreaves G, Azoulay D, Bismuth H. Hepatocellular carcinoma: surgical indications and results. Critical Reviews in Oncology/Hematology 2003;47(1):13-27.
41. Mazariegos 2007 Mazariegos GV, Sindhi R, Thomson AW, Marcos A. Clinical tolerance following liver transplantation: long term results and future prospects. Transplant Immunology 2007;17(2):114-9.
42. Mazzaferro 1996 Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al.Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. New England Journal of Medicine 1996;334(11):693-9.
43. McCormack 2005 McCormack L. Surgical therapy of hepatocellular carcinoma. Europian Journal of Gastroenterology and Hepatology 2005;17(5):497-503.
44. Moher 1998 Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al.Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 1998;352:609-13.
45. Nagasue 1986 Nagasue N, Yukay H. Clinical experience with 118 hepatic resections for HCC. Surgery 1986;99:694-701.
46. Nagorney 1989 Nagorney DM, van Heerden JA. Primary hepatic malignancy: surgical management and determinants of survival. Surgery 1989;106(4):740-8.
47. Ohnishi 1996 Ohnishi K, Yoshioka H, Ito S, Fujiwara K. Treatment of nodular hepatocellular carcinoma larger than 3 cm with ultrasound-guided percutaneous acetic acid injection. Hepatology 1996;24:1379-85.
48. Ohnishi 1998 Ohnishi K, Yoshioka H, Ito S, Fujiwara K. Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatology 1998;27:67-72.
49. Okuda 2002 Okuda K. Where we go with hepatocellular carcinoma: past, present, and future perspectives. Journal of Hepato-Biliary-Pancreatic Surgery 2002;9(6):683-5.
50. Paquet 1991 Paquet KJ. Limited hepatic resection for selected cirrhotic patients with hepatocellular or cholangiocellular carcinoma: a prospective study. British Journal of Surgery 1991;78(4):459-62.
51. Paraskevopoulos 1994 Paraskevopoulos JA. Management options for primary HCC. An overview. Acta Oncologica 1994;33:895-900.
52. Parmar 1998 Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815-34.
53. Poon 2004 Poon RT, Fan ST. Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome. Liver Transplantation 2004;10(2 Suppl 1):S39-S45.
54. Popescu 2005 Popescu I, Ionescu M, Ciurea S, Brasoveanu V, Sarbu-Boeti P, Hrehoret D, et al.Current treatment of hepatocellular carcinoma. Analysis of a series of 123 cases over a 5-year period. Chirurgia 2005;100(4):321-31.
55. RevMan 2003 Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 4.2 for Windows. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2003.
56. Ribero 2006 Ribero D, Abdalla EK, Thomas MB. Liver resection in the treatment of hepatocellular carcinoma. Expert Review of Anticancer Therapy 2006;6(4):567-79.
57. Royle 2003 Royle P, Milne R. Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches. International Journal of Technology Assessment in Health Care 2003;19(4):591-603.
58. Schoppmeyer 2007 Schoppmeyer K, Wagner AD, Mossner J, Fleig W. Percutanous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma (Protocol). Cochrane Database of Systematic Reviews 2007, Issue 3. Art. No.: CD006745. DOI:10.1002/14651858.CD006745.
59. Schulz 1995 Schulz KF, Chalmers I. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-12.
60. Sherman 2005 Sherman M. Hepatocellular carcinoma: epidemiology, risk factors, and screening. Seminars in Liver Disease 2005;25(2):143-54.
61. Song 2004 Song TJ, Ip EW, Fong Y. Hepatocellular carcinoma: current surgical management. Gastroenterology 2004;127(5 Suppl 1):S248-S260.
62. Sotiropoulos 2006 Sotiropoulos GC, Lang H, Frilling A. Resectability of hepatocellular carcinoma: evaluation of 333 consecutive cases at a single hepatobiliary specialty center and systematic review of the literature. Hepato-Gastroenterology 2006;53(69):322-9.
63. Takayama 1998 Takayama T. Early hepatocellular carcinoma as an entity with high rate surgical rate. Hepatology 1998;28:1241-6.
64. Takayama 2000 Takayama T. Adoptive immunotherapy to lower postsurgical recurrence rate of hepatocellular carcinoma. Lancet 2000;359:1734-9.
65. Taylor-Robinson 1997 Taylor-Robinson SD. Increase in primary liver cancer in the UK, 1979-1994. Lancet 1997;350:1142-3.
66. Verhoef 2004 Verhoef C, de Man RA, Zondervan PE, Eijkemans MJ, Tilanus HW, Ijzermans JN. Good outcomes after resection of large hepatocellular carcinoma in the non-cirrhotic liver. Digestive Surgery 2004;21(5-6):380-6.
67. Wallner 1994 Wallner I, Hartmann H. Current therapeutic strategies in HCC, Part 1. Leber Magen Darm 1994;24:150-4.
68. Yeh 2002 Yeh CN, Chen MF, Lee WC, Jeng LB. Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis. Journal of Surgical Oncology 2002;81(4): 195-202.